Nieves Chanza-Martinez
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
The Impact of Testicular Prosthesis on Cancer Patients' Intimacy and Quality of Sex Life.
Journal: Cureus
Published: October 06, 2025
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 15, 2025
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.
Journal: Journal for immunotherapy of cancer
Published: May 07, 2025
Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128).
Journal: World journal of urology
Published: October 06, 2024
Evaluating response to radium-223 using 68Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer.
Journal: Annals of nuclear medicine
Published: August 23, 2024
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel.
Journal: Clinical nuclear medicine
Published: June 29, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.
Journal: Cancers
Published: January 03, 2023
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
Journal: EClinicalMedicine
Published: November 24, 2022
CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.
Journal: Cancer investigation
Published: September 14, 2022
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Journal: The oncologist
Published: February 05, 2022
Last Updated: 09/26/2026